Funding for this research was provided by:
The University of Queensland
Article History
Accepted: 8 August 2022
First Online: 15 September 2022
Declarations
:
: K. R. R. declares that he has no conflict of interest.S. R. K. declares that she has no conflict of interest.J. C. Q. V has participated in Advisory Board engagements for Mallinckrodt Pharmaceuticals (maker of terlipressin), Bayer, Travere Therapeutics, and Calliditas.